Methylisothiazolinone – what is it and can it affect me?
Methylisothiazolinone is otherwise known as MIT.
What is it in?
- Shampoo (Head and Shoulders, Suave, Clairol)
- Pantene hair conditioner
- Revlon hair color
- Hand lotions
When taking a shower, it is doubtful the thought, “How is this shampoo affecting my nerves ?” ever comes to mind. Though perhaps more people should pay attention to the products they are using on a daily basis, as some contain a potentially dangerous chemical, methylisothiazolinone (MIT), which may have detrimental effects on the nervous system. While the purpose of MIT is to prevent bacteria from developing, researchers found that contact with it restricted growth of axons and dendrites of immature nerves found in rat brain cells. The rat studies also showed that chronic exposure to this chemical led to a malfunction in the way neurons communicate with one another. One researcher explained that direct exposure to high concentrations of MIT would irritate the skin because it can damage skin cells. Yet since the chemical only affects the cells it comes in contact with, there is no way the chemical can get into the bloodstream and go to the brain.
Based on their findings, researchers concluded that people working directly with MIT are the most at risk; however, additional tests still must be administered in order to determine if MIT is harmful to humans in the concentrations found in household products.
Is there reason to examine what we are using every day. Certainly. That’s why I became an Arbonne distributor. I worked for ICI Australia for 14 years and saw first hand the nasty nature of chemicals.
Arbonne is Pure, Safe, Beneficial using the best nature can provide and the least chemicals that man produces.
Here’s some more information for you.
· Get the book – Consumers’ Guide to Cosmetics by Ruth Winter · Incidence of Adverse Drug Reactions in Hospitalized Patients o Journal of the American Medical Association (JAMA) 1998, Volume 279. · Menopausal Estrogen and Estrogen-Progestin Replacement Therapy and Breast Cancer Risk o JAMA 2000, Volume 283. · Health Affairs March/April 2002;21:207-217o Healthcare spending will top $2.8 trillion in the US by 2011, driving an even larger chunk of the nation’s gross domestic product (GDP) than previously forecast, government actuaries reported on March 12.
o Spending may reach 17% of GDP by 2011, up from 13.2% in 2000,according to actuaries at the Centers for Medicare and Medicaid Services (CMS). Said another way, annual healthcare spending by 2011 will rise to $9,216 per person in America — double the amount spent per capita in 2000.
Filed under: News Reports |